Table 3.
Baseline and 12-week modified Medical Research Council dyspnea scale scores.
| Time of assessment | Group 1: LABA/ICS (n = 15) | Group 2: LAMA/ICS (n = 15) | Group 3: LABA/LAMA (n = 15) | F value | P value |
|---|---|---|---|---|---|
| Baseline | |||||
| Range | 2.00-4.00 | 2.00-4.00 | 2.00-4.00 | 0.644 | 0.530 |
| Mean (SD) | 3.07 (0.70) | 3.33 (0.72) | 3.07 (0.80) | ||
| Median | 3.00 | 3.00 | 3.00 | ||
| 12 wk after treatment | |||||
| Range | 1.00-3.00 | 1.00-3.00 | 1.00-3.00 | 0.292 | 0.749 |
| Mean (SD) | 1.73 (0.80) | 1.73±0.80 | 1.93 (0.88) | ||
| Median | 2.00 | 2.00 | 2.00 | ||
| Paired t test | 6.325 | 12.220 | 8.500 | ||
| P value | 0.0001* | 0.0001* | 0.0001* |
ICS = inhaled corticosteroid; LABA = long-acting β2-agonist; LAMA = long-acting muscarinic antagonist.
⁎
Significant difference with ANOVA test.